European Medical (ALEMS) | Stock Overview & Key Data
European Medical Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €2,956.45 on February 27, 2017
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
European Medical
ALEMS
|
20.74M Small-cap | 1.63% | 2.04% | 1.01% | -7.41% | 6.84% | 6.38% | -16.39% | -95.91% | -99.74% | -99.78% | -99.78% |
|
UCB S.A
UCB
|
50.14B Large-cap | -0.69% | 9.37% | 1.69% | 8.86% | 10.67% | 68.19% | 220.47% | 222.73% | 332.23% | 618.13% | 618.13% |
|
Argenx SE
ARGX
|
41.43B Large-cap | -0.26% | 9.81% | 24.18% | 24.18% | 24.18% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% |
|
Celyad Oncology S.A
CYAD
|
14.10M Small-cap | -7.14% | -10.34% | -21.21% | 44.44% | 44.44% | -35.00% | -50.94% | -94.34% | -99.36% | -98.71% | -98.71% |
|
Biosenic SA
BIOS
|
1.57M Small-cap | N/A | N/A | N/A | N/A | N/A | -80.00% | -98.25% | -99.73% | -99.94% | -98.97% | -98.97% |
| N/A | -1.22% | 14.47% | 5.09% | 6.07% | 7.58% | 85.71% | 225.88% | 200.37% | 364.29% | 681.77% | 681.77% |
Ownership & Short Interest
Calculate Your European Medical Investment Returns
Long-Term Investment Performance Analysis
European Medical stock price in Jul 2016 was €1,877.22, A €1,000.00 lump sum investment in European Medical made 9 years ago would be worth approximately €2.66 today, representing a negative return of -99.73%. This translates to an annualized return (CAGR) of -45.05%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ALEMS's 52-week high and low?
- In the last 52 weeks, European Medical reached a high of €5.75 (on September 19, 2025) and a low of €4.20 (on September 15, 2025).
- What is the market cap and P/E ratio for ALEMS?
- Curious about European Medical's size and valuation? Its market capitalization stands at 20.74M. When it comes to valuation, the P/E ratio (trailing twelve months) is 11.14, and the forward P/E (looking ahead) is N/A.
- Does ALEMS pay dividends? If so, what's the yield?
- As for dividends, European Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are European Medical's main competitors or similar companies to consider before investing?
When looking at European Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UCB S.A
UCB50.14B Healthcare Biotechnology 68.19% 220.47% Argenx SE
ARGX41.43B Healthcare Biotechnology 29.01% 29.01% Celyad Oncology S.A
CYAD14.10M Healthcare Biotechnology -35.00% -50.94% Biosenic SA
BIOS1.57M Healthcare Biotechnology -80.00% -98.25% Financière de Tubize
TUBN/A Healthcare Biotechnology 85.71% 225.88% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for European Medical Solutions S.à r.l.? (e.g., ROE, Debt/Equity)
- To get a sense of European Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.43%, the Debt to Equity ratio from the most recent quarter is 154.89, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALEMS?
- Looking at European Medical's growth, its revenue over the trailing twelve months (TTM) was €53M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.80%, and quarterly earnings saw a YoY growth of 362.50%.
- How much of ALEMS stock is held by insiders and institutions?
- Wondering who owns European Medical stock? Company insiders (like executives and directors) hold about 90.75% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.02%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.